NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
Back to search
Official data from USPTO
VERALOX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VERALOX THERAPEUTICS
ST13
US500000097419155Class
5
Filing
97419155
Registration
8005322
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
10/28/2025
Trademark type
Word
Nice classes
5
Filing date
05/19/2022
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-08-00
First use in commerce
2023-08-00
Drawing code
4
Owner type
03
Owner location
Frederick, MD, US
Examiner
WILSON,MARYNELLE WEST
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Veralox Therapeutics Inc.
Representatives
Susan Piascik Christoff Cooley LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productschemical and small molecule preparations for use in treatment of blood disorders; pharmaceutical formulations for treatment of blood disorders
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/03/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/03/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/30/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/30/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/09/2025
GNRT
NON-FINAL ACTION E-MAILED
04/09/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/09/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/21/2025
IUAF
USE AMENDMENT FILED
12/10/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2024
EX3G
SOU EXTENSION 3 GRANTED
12/10/2024
EXT3
SOU EXTENSION 3 FILED
12/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/16/2024
EX2G
SOU EXTENSION 2 GRANTED
05/15/2024
EXT2
SOU EXTENSION 2 FILED
05/15/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2023
EX1G
SOU EXTENSION 1 GRANTED
12/11/2023
EXT1
SOU EXTENSION 1 FILED
12/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/11/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/13/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2023
PUBO
PUBLISHED FOR OPPOSITION
04/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/16/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/16/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/16/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/16/2023
DOCK
ASSIGNED TO EXAMINER
03/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2022
NWAP
NEW APPLICATION ENTERED
05/23/2022
Continuous trademark protection
Get notified about every new filing that threatens VERALOX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.